Lacticaseibacillus Rhamnosus GG Supplementation in Active Ankylosing Spondylitis

This clinical trial record focuses on Lacticaseibacillus rhamnosus GG supplementation in active ankylosing spondylitis. The primary medical condition investigated in the study is ankylosing spondylitis. As part of the research, a dietary supplement containing Lacticaseibacillus rhamnosus GG was administered as an intervention. A second intervention evaluated in this study was a placebo. The sponsor and organizer of this research project is Acibadem University. According to the official records, this clinical study is currently completed.